Objective

Patients with spinal cord injury suffer from urinary tract infection (UTI) repeatedly. An assessment of the professional practices in UTI has been set up since 2013. The aim of this study is to assess the impact of physician/pharmacist’s collaboration on 3 quality indicators (QI) in UTI during 2014/2015.

Material/patients and methods

At the beginning of the treatment and then twice a week, pharmacists validate every antibiotic therapy. QI assess the conformity of the duration, the conformity of the dosage and the conformity to the susceptibility testing. The following variables were recorded for each patient: sex, renal clearance, weight, kind of UTI, antibiotic therapy. Has a patient had many UTI during the study, he has been included several times. We compare treatments with Société de pathologie infectieuse de langue française’s (SPILF) recommandations in effect at the analyse’s time. We present our balance sheet 2014/2015.

Results

The study population included 154 patients (64% men) and 253 UTI were registered. The mean age of patients is 51.4 ± 15.4. Pharmacological interventions (29) allow to improve antibiotic therapy: duration and dosage (31, 44.9%), frequency and route of administration (23, 33.3%) and choice of molecule (8, 11.6%). There is no link between class of antibiotics and pharmacological intervention (p-value > 0.05). The rate of acceptance of pharmacological intervention is higher (79.7%). The level of the compliance of the duration is 96.4%, of the dosage 98.9% and of the susceptibility testing 99.2%.

Discussion – conclusion

Appropriateness rate in the management UTI without physician/pharmacist’s collaboration is between 40 and 80% according to others studies (1,2). Collaboration and pharmaceutical analyses provide value-added in the quality of antibiotic treatment. Take to simple steps to improve proper use of antibiotics.